Aaron Siri
speaker
358 appearances
2 recordings
2 series
first heard Nov 2024
last heard Dec 2024
Aaron Siri’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
Well, the way that I, you know, we've got 40 folks at our firm that just do vaccine-related work. I believe we have the largest vaccine practice in the world that doesn't represent pharmaceutical companies. 15 of those folks do vaccine injury claims. We don't sue pharmaceutical companies typically. We just sue in that program.
And we sue the federal government in a program called the Vaccine Injury Compensation Program. That's a very limited program. We'll compensate very limited things. But when we do that, We want to assess the safety and efficacy of the product, particularly obviously the safety.
We want to see if a mother calls you and says, look, I gave my two month old a Hep B shot or a few vaccines and then ended up with a grand mal seizure within ten minutes. Well, how do we determine causation? How can we show whether the vaccine caused that issue?
Well, normally the way you do it is you have a prospective trial that compares an exposed group to an unexposed group, commonly known as a clinical trial.
You would just do that. And so with COVID vaccine, to your example, if somebody asked you, Dr. Drew, like you were saying, well, should I give them the booster? You'd want to look at the clinical trial data for that vaccine. Well, good luck finding it because it doesn't exist for most of the boosters. They're not using clinical trials. And unfortunately, the reality is that
You know, there's a giant delta between the clinical trials for vaccines and the clinical trials for drugs. When it comes to drugs, if I may, most package inserts, if you pull up that piece of paper in the box, you know, when you get the drug, there's that big piece of paper.
You open it up, there's section 6.1, and as required by federal law, it will summarize what was the clinical trial vis-a-vis safety relied upon to license that product. Well, for many drugs, like look at the top-selling Pfizer drugs, Embryol, Leroquist, Lipitor. You will see they're multi-year clinical trials that review safety against the placebo.
So you can compare those that are exposed, not exposed, and you can look at all the body systems. You know, neurological system, immune system, cardiovascular system. You can see the delta between those. But with vaccines… You don't have that. And by the way, don't take my word for it, it's all on the FDA website.
You can go to FDA licensed vaccines, and on one page, you can look at the clinical trials to license most vaccines. Unfortunately, you don't have that data. So you don't have it for the booster. For the underlying, the initial COVID vaccine product, at least for Pfizer, And Moderna, you do have at least two months on average of placebo-controlled data.
But I'll tell you, that's in six months of safety for approximately for rare events. But that's an aberration. That is rare. You're not going to find that for any clinical trial for vaccines. You will find it for drugs.
Yeah, there were problems in the manner that you're describing, but may I one-up you? And it's this. Go ahead. They said it's 95% effective. What was that based on? It was based on the fact that about 100 and something individuals, and this was for Pfizer initially, 100 and something individuals had some symptoms consistent with COVID-19, and they tested positive.
and about, I forgot what it was, was a single digit of individuals in the vaccinated group and the exposed group had some symptoms. And they said, therefore, it's 95% effective. That wasn't measuring, you know, when they gave it emergency use authorization, that wasn't measuring death, hospitalization, or severe outcomes. It was just measuring those symptoms and
You know, we brought the lawsuit that got against the FDA when they wanted to hide the data for 75 years, and we've gotten a lot of that data now, not all of it, to license the Pfizer COVID-19 vaccine. And when you look at that data, what you see is that there are hundreds and hundreds of individuals who had some symptoms consistent maybe with COVID, but were not tested.
So how do you know that those who were tested were not cherry-picked, were not an aberration? You know, they were telling every single American to test almost daily, but yet they couldn't just test everybody in this clinical trial, you're telling me? Really?
And you know, had they done that, by the way, just once a week tested everybody, the 30 to 42,000 individuals, depending on the trial, you would have also known whether or not it prevented transmission, but they didn't do that. I'll add one last point, if I may, and it's this. While they did a statistical comparison with regards to the efficacy, that 95%,
When it came to deaths, that's not what they did.
They didn't look at deaths at all. No, they did.
Well, the severe outcomes was an endpoint. Death is a severe outcome. So it would certainly have been on the safety front. It measured serious adverse events. If you go to the FDA definition of serious adverse event, it has a list. It's the fine term for the clinical trial. Death is one of them. So it did look at deaths as a safety outcome, safety outcome.
And in that regard, if you look at all cause death mortality in the trials, there were 21 deaths. excuse me, one, I believe, deaths in the vaccinated group for the Pfizer trial and around 15 deaths in the placebo group. But did they do a statistical comparison? By the way, this again, not me. This is in the FDA documentation. You can pull it up yourself.
It's on the FDA website in the summary documentation. But did they do a comparison, statistical comparison? No. Instead, they let Pfizer explain away each death individually and say, well, none of them were related to the vaccine or to the placebo.
Showing 301–320 of 358 · page 16 of 18
← Previous
Next →